Company intelligence / Profile preview

lkapharm

Ownership: Private
Development stage: Other

Overview

IkaPharm is an Israeli pharmaceutical company focused on the development, manufacturing, and distribution of generic and branded pharmaceutical products. The company specializes in providing high-quality medications across various therapeutic areas, including pain management, cardiology, and gastroenterology. IkaPharm operates as a key player in the Israeli healthcare market, often partnering with international manufacturers to bring essential treatments to local patients. Their business model encompasses both the production of finished dosage forms and the strategic distribution of specialized medical products.

Therapeutic areas: CardiovascularInfectious DiseasesNeurologyGastroenterology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on lkapharm.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on lkapharm.